Longitudinal changes in physiological, radiological, and health status measurements in α1-antitrypsin deficiency and factors associated with decline

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 10 I, 2001, Pages 1805-1809

  Dowson, Lee J ^a   Guest, Peter J ^a   Stockley, Robert A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Computed tomography; Exacerbations; Health status; Obstructive lung diseases

Indexed keywords

ALPHA 1 ANTITRYPSIN; BRONCHODILATING AGENT; CARBON MONOXIDE; TRANSFER FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; EMPHYSEMA; ENZYME DEFICIENCY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HUMAN; LONGITUDINAL STUDY; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MALE; MEASUREMENT; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING;

EID: 0035891572     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.10.2106036     Document Type: Article

References (24)

1. Alpha 1-antitrypsin deficiency: Memorandum from a WHO meeting
2. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin
3. Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: A new hypothesis with supporting data
4. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor
5. A clinical trial of efficacy of antiproteolytic therapy: Can it be done?
6. A randomized clinical trial of alpha-1 antitrypsin augmentation therapy
7. Exercise capacity predicts health status in alpha(1)-antitrypsin deficiency
8. Definition and classification of chronic bronchitis, clinical and epidemiological purposes; a report to the Medical Research Council by their committee on the etiology of chronic bronchitis
9. Toward a consensus definition for COPD exacerbations
10. Guidelines for the measurement of respiratory function
11. Arterialised earlobe blood gas analysis: An underused technique
12. High-resolution computed tomography in cystic lung disease
13. Density mask. An objective method to quantitate emphysema using computed tomography
14. The St George's Respiratory Questionnaire
15. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire
16. SF-36 health survey
17. The effects of age, sex, lung size and hyperinflation on CT lung densitometry
18. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1
19. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease
20. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ)
21. Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT
22. Assessment of the progression of emphysema by quantitative analysis of spirometrically-gated CT images
23. High-resolution computed tomography scanning in a1-antitrypsin deficiency: Relationship to lung function and health status
24. Variation in distribution of emphysema measured by CT density mask analysis in different phenotypes for alpha-1-antitrypsin deficiency